ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

T-Therapeutics Limited

T-Therapeutics Limited is an active company incorporated on 10 May 2022 with the registered office located in , . T-Therapeutics Limited was registered 3 years ago.
Status
Active
Active since incorporation
Company No
14097070
Private limited company
Age
3 years
Incorporated 10 May 2022
Size
Medium
Balance sheet is under £27M
Under 250 employees
Confirmation
Submitted
Dated 23 May 2025 (7 months ago)
Next confirmation dated 23 May 2026
Due by 6 June 2026 (4 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
One Granta
Granta Park
Great Abington
CB21 6DP
United Kingdom
Address changed on 9 Apr 2025 (9 months ago)
Previous address was Abington Hall Granta Park Cambridge CB21 6AL United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
7
Shareholders
13
Controllers (PSC)
1
Director • Managing Partner • Italian,french • Lives in France • Born in Feb 1969
Director • Venture Capital • American • Lives in United States • Born in Aug 1988
Director • British • Lives in England • Born in Aug 1987
Director • French • Lives in UK • Born in May 1976
Director • Ceo • British • Lives in UK • Born in Apr 1974
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Arborea Ltd
Luke Elliott Rajah is a mutual person.
Active
Puraffinity Ltd
Luke Elliott Rajah is a mutual person.
Active
Crypto Quantique Limited
Luke Elliott Rajah is a mutual person.
Active
Hexagonfab Limited
Luke Elliott Rajah is a mutual person.
Active
Mach42 Limited
Luke Elliott Rajah is a mutual person.
Active
Forefront RF Ltd
Luke Elliott Rajah is a mutual person.
Active
Phlux Technology Ltd
Luke Elliott Rajah is a mutual person.
Active
Cellular Origins Limited
Luke Elliott Rajah is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£8.73M
Increased by £3.07M (+54%)
Turnover
Unreported
Same as previous period
Employees
69
Increased by 36 (+109%)
Total Assets
£16.48M
Increased by £5.92M (+56%)
Total Liabilities
-£3.32M
Increased by £2.06M (+164%)
Net Assets
£13.16M
Increased by £3.86M (+41%)
Debt Ratio (%)
20%
Increased by 8.23% (+69%)
Latest Activity
Viet-Anh Anne Horgan Appointed
1 Month Ago on 1 Dec 2025
Robert Giles Tansley Resigned
1 Month Ago on 1 Dec 2025
David Hung Resigned
1 Month Ago on 30 Nov 2025
Mr Luke Rajah Appointed
2 Months Ago on 22 Oct 2025
Group Accounts Submitted
4 Months Ago on 19 Aug 2025
Confirmation Submitted
7 Months Ago on 5 Jun 2025
Notification of PSC Statement
7 Months Ago on 5 Jun 2025
Allan Bradley (PSC) Resigned
8 Months Ago on 14 May 2025
Ms Theodora Harold Appointed
8 Months Ago on 9 May 2025
Nihal Sinha Details Changed
1 Year 5 Months Ago on 25 Jul 2024
Get Credit Report
Discover T-Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Appointment of Viet-Anh Anne Horgan as a director on 1 December 2025
Submitted on 9 Dec 2025
Termination of appointment of Robert Giles Tansley as a director on 1 December 2025
Submitted on 8 Dec 2025
Termination of appointment of David Hung as a director on 30 November 2025
Submitted on 8 Dec 2025
Memorandum and Articles of Association
Submitted on 5 Dec 2025
Change of share class name or designation
Submitted on 7 Nov 2025
Change of share class name or designation
Submitted on 7 Nov 2025
Statement of capital following an allotment of shares on 24 October 2025
Submitted on 3 Nov 2025
Resolutions
Submitted on 31 Oct 2025
Memorandum and Articles of Association
Submitted on 31 Oct 2025
Appointment of Mr Luke Rajah as a director on 22 October 2025
Submitted on 29 Oct 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year